The COVID-19 viral 3a protein forms a potassium channel that can be inhibited by antiarrhythmic drugs

Back

EHRA Premium Access

The COVID-19 viral 3a protein forms a potassium channel that can be inhibited by antiarrhythmic drugs

Session: Young Investigator Award - Basic and Translational Science

Topic: Arrhythmias

Speaker: Doctor F. Wiedmann (Heidelberg, DE)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Doctor Felix Wiedmann

University Hospital Heidelberg, Heidelberg (Germany)

1 presentation

0 follower

4 more presentations in this session

Trapped re-entry: a dormant source of arrhythmia

Speaker: Doctor T. De Coster (Leiden, NL)

Access

Abstract

Video

An automated algorithm minimising ATP failure: re-initiation to enhance anti-tachycardia pacing efficacy

Speaker: Doctor S. Qian (London, GB)

Endurance training induced cellular electrophysiological remodeling in a small and a large animal athlete's heart model

Speaker: Doctor L. Topal (Szeged, HU)

Adrenergic stimulation amplifies the difference in beat-to-beat variability between the scar border zone and remote region

Speaker: Mr D. Vermoortele (Leuven, BE)

Access the full session

Young Investigator Award - Basic and Translational Science

Speakers: Doctor F. Wiedmann, Doctor T. De Coster, Doctor S. Qian, Doctor L. Topal, Mr D. Vermoortele

Access

Video

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources